StockData

PRF Technologies Ltd. (PRFX) KPIs and segments

PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 6/30
$0.79+0.04 (+5.82%)

Close on Nov 12, 2026Market cap $653.53KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive PRF Technologies's business

PRF Technologies's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
FY2025
Solar($M)
0.02
Clinical Development($M)
0
Solar($M)
-1.90
Clinical Development($M)
-3.22
Clinical Development($M)
0
Solar($M)
-0.05

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-03-26.

See a number that looks wrong?